Erratum to: Slug signaling is up-regulated by CCL21/CCR7 to induce EMT in human chondrosarcoma [Med Oncol, (2015), 32:2, 10.1007/s12032-014-0478-6];Slug signaling is up-regulated by CCL21/CXCR7 to induce EMT in human chondrosarcoma

Medical Oncology

Volumn 32, Issue 2, 2015, Pages

  Li, Guosong ^a   Yang, Yanjun ^a   Xu, Siliang ^a   Ma, Lifeng ^a   He, Mingtang ^a   Zhang, Ziqing ^a  

^a Longgang Central Hospital   (China)

Author keywords

CXCR7; EMT; Human chondrosarcoma; Slug

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE RECEPTOR CXCR7; NERVE CELL ADHESION MOLECULE; PROTEIN KINASE B; SECONDARY LYMPHOID TISSUE CHEMOKINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR SLUG; UVOMORULIN; CCL21 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CXCR; CXCR7 PROTEIN, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CELL MIGRATION; CHONDROSARCOMA; CHONDROSARCOMA CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; GENE SWITCHING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; BONE TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE;

ADULT; BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; CHEMOKINE CCL21; CHONDROSARCOMA; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, CXCR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84920153217     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0508-z     Document Type: Erratum

References (25)

1. Randall RL, Bruckner J, Lloyd C, et al. Sacral resection and reconstruction for tumors and tumor-like conditions. Orthopedics. 2005;28:307–13.
2. Bergh P, Gunterberg B, Meis-Kindblom JM, et al. Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer. 2001;91:1201–12.
3. Bovée JV, Cleton-Jansen AM, Taminiau AH, et al. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncol. 2005;6:599–607.
4. Tan ML, Shao P, Friedhuber AM, et al. The potential role of free chitosan in bone trauma and bone cancer management. Biomaterials. 2014;35:7828–38.
5. Uchida A, Seto M, Hashimoto N, et al. Molecular diagnosis and gene therapy in musculoskeletal tumors. J Orthop Sci. 2000;5:418–23.
6. Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320–9.
7. Ishikawa T, Shimizu T, Ueki A, et al. Twist2 functions as a tumor suppressor in murine osteosarcoma cells. Cancer Sci. 2013;104:880–8.
8. Casas E, Kim J, Bendesky A, et al. Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 2011;71:245–54.
9. Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7:re8.
10. Tirino V, Camerlingo R, Bifulco K, et al. TGF-beta1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Cell Death Dis. 2013;4:e620.
11. Eberlein C, Rooney C, Ross SJ, et al. E-cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin alphavbeta6 and maintained through TGF beta signalling. Oncogene. 2014. doi:10.1038/onc.2013.600.
12. Liu RY, Zeng Y, Lei Z, et al. JAK/STAT3 signaling is required for TGF-beta-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol. 2014;44:1643–51.
13. Jing Y, Han Z, Zhang S, et al. Epithelial-mesenchymal transition in tumor microenvironment. Cell Biosci. 2011;1:29.
14. Zheng H, Kang Y. Multilayer control of the EMT master regulators. Oncogene. 2014;33:1755–63.
15. Nieto MA, Sargent MG, Wilkinson DG, et al. Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science. 1994;264:835–59.
16. Haupt S, Alsheich-Bartok O, Haupt Y. Clues from worms: a Slug at Puma promotes the survival of blood progenitors. Cell Death Differ. 2006;13:913–5.
17. Umar S. Enteric pathogens and cellular transformation: bridging the gaps. Oncotarget. 2014;5:6573–5.
18. Ding W, You H, Dang H, et al. Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion. Hepatology. 2010;52:945–53.
19. Cicchini C, Laudadio I, Citarella F, et al. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling. Exp Cell Res. 2008;314:143–52.
20. Leckband D. Beyond structure: mechanism and dynamics of intercellular adhesion. Biochem Soc Trans. 2008;36:213–20.
21. Hsu YL, Hou MF, Kuo PL, et al. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. Oncogene. 2013;32:4436–47.
22. Li Y, Jia L, Ren D, et al. Axl mediates tumor invasion and chemosensitivity through PI3K/Akt signaling pathway and is transcriptionally regulated by slug in breast carcinoma. IUBMB Life. 2014;66:507–18.
23. Suman S, Kurisetty V, Das TP, et al. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells. Mol Carcinog. 2014;53:E151–60.
24. Li Y, Zhao Z, Xu C, et al. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Cancer Lett. 2014;355:130–40.
25. He LC, Gao FH, Xu HZ, et al. Ikaros inhibits proliferation and, through upregulation of Slug, increases metastatic ability of ovarian serous adenocarcinoma cells. Oncol Rep. 2012;28:1399–405.